Corey Knowles

Maybe there's a solution where at some point we were talking about how you wouldn't use a chat window to do this, but maybe you would use a chat window to talk about a sinus infection.

Or maybe, you know, or I strained my back last night.

Maybe there's a solution where having access to that.

And telehealth has come a long way and been, in my opinion, very beneficial toward just getting little annoying stuff treated more quickly.

Like the fact that

I can wake up with, you know, sinus pain and I can really quickly set a quick appointment.

And in 20 minutes, I'm on FaceTime with a doctor.

An hour from now, I've got a prescription sitting at Walgreens.

And that's pretty awesome.

But it's very different when you get into these bigger issues like that.

What would you say are the biggest barriers that prevent a tool like CureWise, for example, from reaching millions of cases?

cancer patients who could benefit today?

At its core, it's harm reduction is what we're talking about, I would say, which is a sometimes unpopular topic.

But I mean, at its core, the idea that an imperfect solution is better than a current solution is absolutely something that has to be balanced with a need slash desire to regulate new technologies.

You know, we're at a time right now that is really complex from not just within our country, but globally, like, you know.

There's a really tightrope-type dance you need to walk with regard to regulation right now, I feel like.

I think the ability to simulate human trials on new ideas could help bump things through phases a little quicker, too, as a part of this.

Hopefully, you know, trying to think of like, you know, because you don't want to you don't want to use a person as a guinea pig.

However, for some people, depending on your situation, that might be preferred.

I don't know as you know, on an individual basis, but.